Human apolipoprotein E4(APOE4)is an important risk factor for late-onset Alzheimer’s disease(AD).However,little progress has been made for the detection of APOE4,and most of existing detection methods suffer from tim...Human apolipoprotein E4(APOE4)is an important risk factor for late-onset Alzheimer’s disease(AD).However,little progress has been made for the detection of APOE4,and most of existing detection methods suffer from time-consuming process and expensive instruments.This study firstly proposed a simple and sensitive electrochemical method for detection of APOE4 based on carboxyl-rich CeZnO nanoparticles.Under the optimal conditions,the fabricated immunosensor exhibited a good linear relationship ranging from 10 to 100 ng/mL with the detection limit of 1.8 ng/mL(S/N=3).The proposed electrochemical immunosensor had excellent selectivity,reproducibility and stability.Good performance was observed for sensitive determination of APOE4 in human serum sample,which provided a strong support for the detection of APOE4 and early clinical prevention of AD.展开更多
基金The National Youth Foundation of China(Grant No.81803487)National Natural Science Foundation(Grant No.81673392)China Postdoctoral Science Foundation(Grant No.2018M631285).
文摘Human apolipoprotein E4(APOE4)is an important risk factor for late-onset Alzheimer’s disease(AD).However,little progress has been made for the detection of APOE4,and most of existing detection methods suffer from time-consuming process and expensive instruments.This study firstly proposed a simple and sensitive electrochemical method for detection of APOE4 based on carboxyl-rich CeZnO nanoparticles.Under the optimal conditions,the fabricated immunosensor exhibited a good linear relationship ranging from 10 to 100 ng/mL with the detection limit of 1.8 ng/mL(S/N=3).The proposed electrochemical immunosensor had excellent selectivity,reproducibility and stability.Good performance was observed for sensitive determination of APOE4 in human serum sample,which provided a strong support for the detection of APOE4 and early clinical prevention of AD.
